Biosafety Practices for In Vivo Viral-Mediated Gene Therapy in the Health Care Setting.

As biotechnology continues to advance, so will the challenges of incorporating novel therapies into the clinical setting. Health systems must educate themselves on the current recommendations and maintain competency of this evolving science to ensure the safety of patients, families, and staff in the clinical environment.